• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与铍致敏和慢性铍病相关的单成分和多成分材料在吞噬溶酶体模拟液中的溶解行为差异。

Differences in dissolution behavior in a phagolysosomal simulant fluid for single-constituent and multi-constituent materials associated with beryllium sensitization and chronic beryllium disease.

作者信息

Stefaniak Aleksandr B, Day Gregory A, Hoover Mark D, Breysse Patrick N, Scripsick Ronald C

机构信息

Industrial Hygiene and Safety Group, MS K553, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.

出版信息

Toxicol In Vitro. 2006 Feb;20(1):82-95. doi: 10.1016/j.tiv.2005.06.031. Epub 2005 Aug 2.

DOI:10.1016/j.tiv.2005.06.031
PMID:16061346
Abstract

Particle dissolution within macrophage phagolysosomes is hypothesized to be an important source of dissolved beryllium for input to the cell-mediated immune reaction associated with development of beryllium sensitization and chronic beryllium disease (CBD). To better understand the dissolution of beryllium materials associated with elevated prevalence of sensitization and CBD, single-constituent (beryllium oxide (BeO) particles sampled from a screener operation, finished product BeO powder, finish product beryllium metal powder) and multi-constituent (particles sampled from an arc furnace during processing of copper-beryllium alloy) aerosol materials were studied. Dissolution rates were measured using phagolysosomal simulant fluid (PSF) in a static dissolution technique and then normalized to measured values of specific surface area to calculate a chemical dissolution rate constant (k) for each material. Values of k, in g/(cm2 day), for screener BeO particles (1.3 +/- 1.9 x 10(-8)) and for BeO powder (1.1 +/- 0.5 x 10(-8)) were similar (p = 0.45). The value of k observed for beryllium metal powder (1.1 +/- 1.4 x 10(-7)) was significantly greater than observed for the BeO materials (p < 0.0003). For arc furnace particles, k (1.6 +/- 0.6 x 10(-7)) was significantly greater than observed for the BeO materials (p < 0.00001), despite the fact that the chemical form of beryllium in the aerosol was BeO. These results suggest that dissolution of beryllium differs among physicochemical forms of beryllium and direct measurement of dissolution is needed for multi-constituent aerosol. Additional studies of the dissolution behavior of beryllium materials in a variety of mixture configurations will aid in developing exposure-response models to improve understanding of the risk of beryllium sensitization and CBD.

摘要

巨噬细胞吞噬溶酶体内的颗粒溶解被认为是溶解铍的一个重要来源,这些溶解铍会进入与铍致敏和慢性铍病(CBD)发展相关的细胞介导免疫反应中。为了更好地理解与致敏和CBD患病率升高相关的铍材料的溶解情况,对单组分(从筛选操作中采集的氧化铍(BeO)颗粒、成品BeO粉末、成品铍金属粉末)和气溶胶多组分材料(铜铍合金加工过程中从电弧炉采集的颗粒)进行了研究。使用吞噬溶酶体模拟液(PSF)通过静态溶解技术测量溶解速率,然后将其归一化为比表面积的测量值,以计算每种材料的化学溶解速率常数(k)。筛选器BeO颗粒的k值(1.3±1.9×10⁻⁸)g/(cm²·天)和BeO粉末的k值(1.1±0.5×10⁻⁸)相似(p = 0.45)。铍金属粉末的k值(1.1±1.4×10⁻⁷)显著高于BeO材料(p < 0.0003)。对于电弧炉颗粒,k值(1.6±0.6×10⁻⁷)显著高于BeO材料(p < 0.00001),尽管气溶胶中铍的化学形式为BeO。这些结果表明,铍的溶解在铍的物理化学形式之间存在差异,对于多组分气溶胶需要直接测量溶解情况。对铍材料在各种混合配置中的溶解行为进行更多研究将有助于开发暴露-反应模型,以更好地理解铍致敏和CBD的风险。

相似文献

1
Differences in dissolution behavior in a phagolysosomal simulant fluid for single-constituent and multi-constituent materials associated with beryllium sensitization and chronic beryllium disease.与铍致敏和慢性铍病相关的单成分和多成分材料在吞噬溶酶体模拟液中的溶解行为差异。
Toxicol In Vitro. 2006 Feb;20(1):82-95. doi: 10.1016/j.tiv.2005.06.031. Epub 2005 Aug 2.
2
Characterization of phagolysosomal simulant fluid for study of beryllium aerosol particle dissolution.用于研究铍气溶胶颗粒溶解的吞噬溶酶体模拟液的特性
Toxicol In Vitro. 2005 Feb;19(1):123-34. doi: 10.1016/j.tiv.2004.08.001.
3
Dissolution of beryllium in artificial lung alveolar macrophage phagolysosomal fluid.铍在人工肺肺泡巨噬细胞吞噬溶酶体液中的溶解。
Chemosphere. 2011 May;83(8):1181-7. doi: 10.1016/j.chemosphere.2010.12.088. Epub 2011 Jan 19.
4
Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease.与慢性铍病患病率相关的铍气溶胶理化性质表征
J Environ Monit. 2004 Jun;6(6):523-32. doi: 10.1039/b316256g. Epub 2004 Mar 22.
5
Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment.硅酸铍矿石研磨过程中产生的气溶胶颗粒的物理化学特性:对风险评估的影响。
J Toxicol Environ Health A. 2008;71(22):1468-81. doi: 10.1080/15287390802349883.
6
Dissolution and nanoparticle generation behavior of Be-associated materials in synthetic lung fluid using inductively coupled plasma mass spectroscopy and flow field-flow fractionation.采用电感耦合等离子体质谱法和流场-流分离法研究合成肺液中与 Be 相关的材料的溶解和纳米颗粒生成行为。
J Chromatogr A. 2011 Jul 8;1218(27):4149-59. doi: 10.1016/j.chroma.2010.11.070. Epub 2010 Dec 4.
7
Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.铍的总质量或肺泡沉积空气传播颗粒的质量,哪一个能更好地预测疾病患病率?一项对铍加工设施的初步研究。
Appl Occup Environ Hyg. 2001 May;16(5):539-58. doi: 10.1080/104732201750169633.
8
Bioavailability of beryllium oxide particles: an in vitro study in the murine J774A.1 macrophage cell line model.氧化铍颗粒的生物利用度:在小鼠J774A.1巨噬细胞系模型中的体外研究
Exp Lung Res. 2005 Apr;31(3):341-60. doi: 10.1080/01902140590918731.
9
Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.铜铍合金工厂中铍致敏和疾病的过程相关风险。
Am J Ind Med. 2005 Mar;47(3):195-205. doi: 10.1002/ajim.20140.
10
Solubility and chemistry of materials encountered by beryllium mine and ore extraction workers: relation to risk.铍矿和矿石开采工人接触的材料的溶解性和化学性质:与风险的关系。
J Occup Environ Med. 2011 Oct;53(10):1187-93. doi: 10.1097/JOM.0b013e31822cfe38.

引用本文的文献

1
25 years of research and regulation: Is nanotechnology safe to commercialize?25年的研究与监管:纳米技术商业化是否安全?
Front Toxicol. 2025 Jul 10;7:1629813. doi: 10.3389/ftox.2025.1629813. eCollection 2025.
2
Compartment-specific protein interactions in beryllium lung disease.铍肺病中特定隔室的蛋白质相互作用。
ERJ Open Res. 2023 Nov 13;9(6). doi: 10.1183/23120541.00138-2023. eCollection 2023 Nov.
3
Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.非感染性肉芽肿性肺病中的固有免疫和适应性免疫。
J Immunol. 2022 Apr 15;208(8):1835-1843. doi: 10.4049/jimmunol.2101159.
4
Dissolution and biodurability: Important parameters needed for risk assessment of nanomaterials.溶解性与生物耐久性:纳米材料风险评估所需的重要参数。
Part Fibre Toxicol. 2015 Apr 28;12:11. doi: 10.1186/s12989-015-0088-2.
5
Pluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injury.Pluronic F108 涂层通过减少溶酶体损伤降低了多壁碳纳米管的肺纤维化潜力。
Nano Lett. 2012 Jun 13;12(6):3050-61. doi: 10.1021/nl300895y. Epub 2012 May 4.
6
Release of beryllium from mineral ores in artificial lung and skin surface fluids.矿石中铍在人工肺和皮肤表面液中的释放。
Environ Geochem Health. 2012 Jun;34(3):313-22. doi: 10.1007/s10653-011-9421-3. Epub 2011 Aug 25.
7
A reconsideration of acute Beryllium disease.急性铍病的再认识
Environ Health Perspect. 2009 Aug;117(8):1250-6. doi: 10.1289/ehp.0800455. Epub 2009 Apr 28.